Q4 2023 Vivos Therapeutics Inc Earnings Call Transcript - Stockxpo - Grow more with Investors, Traders, Analyst and Research

Q4 2023 Vivos Therapeutics Inc Earnings Call Transcript

Mar 28, 2024 / 09:00PM GMT
Operator

Good day, everyone, and welcome to Vivos Therapeutics Fourth Quarter and Full Year 2020 Conference Call. (Operator Instructions)

This conference is being recorded and a replay of today’s call will be available on the Investor Relations section of Vivos website and will remain posted there for the next 30 days.

I will now hand over the call to Julie Gannon, Vivos Investor Relations Officer for introductions and the reading of the Safe Harbor statement. Please go ahead.

Julie GannonVivos Therapeutics Inc – Investment Relations Officer

Thank you, operator. Hello, everyone, and welcome to our conference call. A copy of our earnings press release is available on the Investor Relations section of our website at www.gevo.com. With us on today’s call are Kirk Huntsman, David DeVoe, Chairman and Chief Executive Officer, and Brad Almond, Chief Financial Officer.

Today will review the highlights and financial results for the fourth quarter and full year 2023, as well as more recent

Leave a Reply

Your email address will not be published. Required fields are marked *

scroll to top